6 Result(s)

Article

Reply: Surgery vs chemoRT for locally advanced operable head and neck cancers

K C Soo, J Wee, E H Tan in British Journal of Cancer (2006)

Article

Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison

We compared concurrent combination chemotherapy and radiotherapy with surgery and adjuvant radiotherapy in patients with stage III/IV nonmetastatic squamous cell head and neck cancer. Patients with non-nasopha...

K-C Soo, E-H Tan, J Wee, D Lim, B-C Tai, M-L Khoo, C Goh… in British Journal of Cancer (2005)

Article

Gefitinib is more effective in never-smokers with non-small-cell lung cancer: experience among Asian patients

We retrospectively analysed the results of patients with advanced non-small-cell lung cancer treated with gefitinib to derive clinical factors predictive of response and a favourable survival outcome. Patients...

S-T Lim, E-H Wong, K-L Chuah, S-S Leong, W-T Lim, M-H Tay… in British Journal of Cancer (2005)

Article

Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma

Patients with metastatic nasopharyngeal carcinoma have variable survival outcomes. We previously designed a scoring system to better prognosticate these patients. Here, we report results on validation of this ...

C-K Toh, D Heng, Y-K Ong, S-S Leong, J Wee, E-H Tan in British Journal of Cancer (2005)

Article

Quick-FLIC: validation of a short questionnaire for assessing quality of life of cancer patients

A practically useful measure of quality of life should be simple and quick to complete. A shortened Chinese version of the Functional Living Index – Cancer (FLIC) was recently proposed and was called Quick-FLI...

Y-B Cheung, C Goh, L-C Wong, G-Y Ng, W-T Lim, S-S Leong… in British Journal of Cancer (2004)

Article

A Bayesian re-assessment of two Phase II trials of gemcitabine in metastatic nasopharyngeal cancer

The Simon two-stage minimax design is a popular statistical design used in Phase II clinical trials. The analysis of the data arising from the design typically involves the use of frequentist statistics. This ...

S-B Tan, D Machin, B-C Tai, K-F Foo, E-H Tan in British Journal of Cancer (2002)